Literature DB >> 25754878

APOE ε4 genotype predicts memory for everyday activities.

Heather R Bailey1, Jesse Q Sargent, Shaney Flores, Petra Nowotny, Alison Goate, Jeffrey M Zacks.   

Abstract

The apolipoprotein E (ApOE) ε4 allele is associated with neuropathological buildup of amyloid in the brain, and with lower performance on some laboratory measures of memory in some populations. In two studies, we tested whether ApOE genotype affects memory for everyday activities. In Study 1, participants aged 20-79 years old (n = 188) watched movies of actors engaged in daily activities and completed memory tests for the activities in the movies. In Study 2, cognitively healthy and demented older adults (n = 97) watched and remembered similar movies, and also underwent structural MRI scanning. All participants provided saliva samples for genetic analysis. In both samples we found that, in older adults, ApOE ε4 carriers demonstrated worse everyday memory performance than did ε4 noncarriers. In Study 2, ApOE ε4 carriers had smaller medial temporal lobes (MTL) volumes, and MTL volume mediated the relationship between ApOE genotype and everyday memory performance. These everyday memory tasks measure genetically determined cognitive decline that can occur prior to a clinical diagnosis of dementia. Further, these tasks are easily administered and may be a useful clinical tool in identifying ε4 carriers who may be at risk for MTL atrophy and further cognitive decline that is a common characteristic of the earliest stages of Alzheimer's disease.

Entities:  

Keywords:  APOE; Alzheimer’s disease; aging; episodic memory; everyday memory

Mesh:

Substances:

Year:  2015        PMID: 25754878      PMCID: PMC4537694          DOI: 10.1080/13825585.2015.1020916

Source DB:  PubMed          Journal:  Neuropsychol Dev Cogn B Aging Neuropsychol Cogn        ISSN: 1382-5585


  79 in total

1.  Screening for dementia by memory testing.

Authors:  E Grober; H Buschke; H Crystal; S Bang; R Dresner
Journal:  Neurology       Date:  1988-06       Impact factor: 9.910

2.  Decline in verbal memory during preclinical Alzheimer's disease: examination of the effect of APOE genotype.

Authors:  Kelly L Lange; Mark W Bondi; David P Salmon; Douglas Galasko; Dean C Delis; Ronald G Thomas; Leon J Thal
Journal:  J Int Neuropsychol Soc       Date:  2002-11       Impact factor: 2.892

3.  Event understanding and memory in healthy aging and dementia of the Alzheimer type.

Authors:  Jeffrey M Zacks; Nicole K Speer; Jean M Vettel; Larry L Jacoby
Journal:  Psychol Aging       Date:  2006-09

4.  Longitudinal modeling of age-related memory decline and the APOE epsilon4 effect.

Authors:  Richard J Caselli; Amylou C Dueck; David Osborne; Marwan N Sabbagh; Donald J Connor; Geoffrey L Ahern; Leslie C Baxter; Steven Z Rapcsak; Jiong Shi; Bryan K Woodruff; Dona E C Locke; Charlene Hoffman Snyder; Gene E Alexander; Rosa Rademakers; Eric M Reiman
Journal:  N Engl J Med       Date:  2009-07-16       Impact factor: 91.245

5.  KIBRA: A New Gateway to Learning and Memory?

Authors:  Armin Schneider; Matthew J Huentelman; Joachim Kremerskothen; Kerstin Duning; Robert Spoelgen; Karoly Nikolich
Journal:  Front Aging Neurosci       Date:  2010-02-12       Impact factor: 5.750

6.  Apolipoprotein E epsilon4 influences on episodic recall and brain structures in aging pilots.

Authors:  Maheen M Adamson; Kelly M Landy; Susan Duong; Sabrina Fox-Bosetti; J Wesson Ashford; Greer M Murphy; Michael Weiner; Joy L Taylor
Journal:  Neurobiol Aging       Date:  2008-08-29       Impact factor: 4.673

7.  Anterior temporal lobes and hippocampal formations: normative volumetric measurements from MR images in young adults.

Authors:  C R Jack; C K Twomey; A R Zinsmeister; F W Sharbrough; R C Petersen; G D Cascino
Journal:  Radiology       Date:  1989-08       Impact factor: 11.105

8.  APOE E4 Carriers show prospective memory enhancement under nicotine, and evidence for specialisation within medial BA10.

Authors:  Simon Evans; Marcus A Gray; Nicholas G Dowell; Naji Tabet; Paul S Tofts; Sarah L King; Jennifer M Rusted
Journal:  Neuropsychopharmacology       Date:  2012-11-06       Impact factor: 7.853

9.  The apolipoprotein e antagonistic pleiotropy hypothesis: review and recommendations.

Authors:  Elizabeth R Tuminello; S Duke Han
Journal:  Int J Alzheimers Dis       Date:  2011-02-24

10.  KIBRA genetic polymorphism influences episodic memory in later life, but does not increase the risk of mild cognitive impairment.

Authors:  O P Almeida; S G Schwab; N T Lautenschlager; B Morar; K R Greenop; L Flicker; D Wildenauer
Journal:  J Cell Mol Med       Date:  2008-01-11       Impact factor: 5.310

View more
  6 in total

1.  Event Boundaries in Memory and Cognition.

Authors:  Gabriel A Radvansky; Jeffrey M Zacks
Journal:  Curr Opin Behav Sci       Date:  2017-09-21

2.  Event perception: Translations and applications.

Authors:  Lauren L Richmond; David A Gold; Jeffrey M Zacks
Journal:  J Appl Res Mem Cogn       Date:  2017-06

3.  Event segmentation improves event memory up to one month later.

Authors:  Shaney Flores; Heather R Bailey; Michelle L Eisenberg; Jeffrey M Zacks
Journal:  J Exp Psychol Learn Mem Cogn       Date:  2017-04-06       Impact factor: 3.051

4.  APOE ε4/ε4 homozygotes with early Alzheimer's disease show accelerated hippocampal atrophy and cortical thinning that correlates with cognitive decline.

Authors:  Susan Abushakra; Anton P Porsteinsson; Marwan Sabbagh; Luc Bracoud; Joel Schaerer; Aidan Power; John A Hey; David Scott; Joyce Suhy; Martin Tolar
Journal:  Alzheimers Dement (N Y)       Date:  2020-12-04

5.  Frailty effects on non-demented cognitive trajectories are moderated by sex and Alzheimer's genetic risk.

Authors:  Sherilyn Thibeau; Kirstie McDermott; G Peggy McFall; Kenneth Rockwood; Roger A Dixon
Journal:  Alzheimers Res Ther       Date:  2019-06-21       Impact factor: 6.982

6.  Impaired memory-guided attention in asymptomatic APOE4 carriers.

Authors:  Jacqueline Zimmermann; Claude Alain; Chris Butler
Journal:  Sci Rep       Date:  2019-05-31       Impact factor: 4.379

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.